Membrano-proliferative glomerulonephritis associated with metastatic prostate carcinoma - Should immunosuppressive therapy be considered?

Nephrology Dialysis Transplantation

Volumn 23, Issue 2, 2008, Pages 777-

  Ahmed, Muhammad S ^a   Wong, Christopher F ^a   Abraham, Kottharathil A ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE;

CANCER RISK; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; LETTER; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; QUALITY OF LIFE; TUMOR BIOPSY;

AGED; BONE NEOPLASMS; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PROSTATIC NEOPLASMS;

EID: 44449115614     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm681     Document Type: Letter

References (6)

1. Lee JC, Yamauchi H, Hopper J, Jr. The Association of cancer and the nephrotic syndrome. Ann Intern Med 1966; 64: 41-51
2. Eagen JW. Glomerulopathies of neoplasia. Kidney Int 1977; 11: 297-303
3. Usalan C, Emri S. Membranoproliferative glomerulonephritis associated with small cell lung carcinoma. Int Urol Nerol 1998; 30: 209-213
4. Mazanowska O, Klinger M. Glomerulonephritis in neoplastic disease. Pol Merkur Lekarski 2005; 19: 211-214, Review (Polish)
5. Matsuura H, Sakurai M, Arima K. Nephrotic syndrome due to membranous nephropathy associated with metastatic prostate cancer: rapid remission after initial endocrine therapy. Nephron 2000; 84: 75-78
6. Pai P, Bone JM, McDicken I, Bell GM. Solid tumour and glomerulopathy. Q J Med 1996; 89: 361-367